Cardiology Today Current Issue
The following articles appeared in the print edition of Cardiology Today.
Table of Contents
- Polypill could change secondary prevention strategies for US cardiologists Erik Swain
-
- Treatment of VTE: Warfarin and parenteral anticoagulation still have a role Michael R. Jaff, DO; Ido Weinberg, MD; Jessica Mintz, MD
- Controversy continues to grow over Maintenance of Certification for cardiologists L. Samuel Wann, MD, MACC, FESC
- Appraisal of the National Lipid Association recommendations on cholesterol management Roger S. Blumenthal, MD; Seth S. Martin, MD, MHS, FACC, FAHA, FASPC; Matthew J. Czarny, MD
- FDA approves ablation catheter with flexible tip to treat cardiac arrhythmias
- FDA approves transcatheter pulmonary valve for patients with congenital heart disease
- Percutaneous VAD for right heart support receives FDA approval
- Califf named FDA deputy commissioner for medical products and tobacco
- Prevention of atherosclerosis progression: A multifaceted challenge
-
- Community CVD prevention programs improved outcomes during 40-year period
- Coronary-sinus reducing device appears to benefit patients with angina
- DAYLIGHT: Vitamin D supplementation did not lower BP
- Early noninvasive testing did not impact MI rate in patients with chest pain
- Even slow jogging may reduce risk for death
- High-intensity statin prescriptions often unfilled after CHD events
- IV fluids linked to worse outcomes in patients hospitalized for HF
- Morphine associated with delayed antiplatelet activity in patients with STEMI
-
- New analysis finds no association between statins, cognitive impairment
- New permanent pacemaker implantation after TAVR linked to worse clinical outcomes
- Novel algorithm led to low rate of inappropriate ICD shocks
- One-third of patients would risk shorter life rather than take pill for CVD prevention
- Patients with AF, CHA2DS2-VASc score of 1 may be at low risk for ischemic stroke
- Pneumonia possible risk factor for CVD
- Sleep deprivation in PCI operators increased bleeding risk, not mortality
- Stem cell therapy benefited patients with ischemic cardiomyopathy regardless of age
-
- Study suggests need for greater regulation, oversight of smartphone apps for hypertension management
- UNOS considering new US adult heart allocation system
- Dehydration at time of stroke linked to worse outcomes
- Low vitamin D levels predict stroke severity, worse outcomes
- Low-dose pravastatin reduced atherothrombotic infarction in certain patients with stroke
- Lower systolic BP target may reduce stroke risk
- Mediterranean diet may lower risk for stroke in women
- Risk for cancer elevated in stroke survivors
-
- Trial Scorecard: CADISS
- Trial Scorecard: CHIPS
- Trial Scorecard: COSIRA
- Trial Scorecard: DAYLIGHT
- Trial Scorecard: JSTARS
- Trial Scorecard: NOBORI 1
- Trial Scorecard: SERAPHIN
- Trial Scorecard: XAMI
-